Successful immunosuppressive drug‐free immune tolerance induction in hemophilia B with inhibitor and anaphylaxis to factor <scp>IX</scp>: A case report

Recommendations advise factor IX desensitization before immune tolerance induction in severe hemophilia B, supported by immunosuppression. A child with inhibitor and anaphylaxis to factor IX showed successful immunosuppression-free immune tolerance induction using very low and slowly increasing doses of a factor IX extended-half-life product. Immune tolerance to factor IX based on this protocol merits further study.

Authors

Institutions

Publication Details

Journal
Clinical Case Reports
Published
2024-08-01
DOI
https://doi.org/10.1002/ccr3.9312
Citations
2
Primary Topic
Hemophilia Treatment and Research
Type
article
Field-Weighted Citation Impact
0.91
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Successful immunosuppressive drug‐free immune tolerance induction in hemophilia B with inhibitor and anaphylaxis to factor IX: A case report

Ángeles Palomo Bravo, Ihosvany Fernández Bello, Francisco José López‐Jaime, Daniel Bardan Rebollar et al.
2 citations
Clinical Case Reports
Hemophilia Treatment and Research
0.91
article

Successful immunosuppressive drug‐free immune tolerance induction in hemophilia B with inhibitor and anaphylaxis to factor IX: A case report

Ángeles Palomo Bravo, Ihosvany Fernández Bello, Francisco José López‐Jaime, Daniel Bardan Rebollar, Rosario Prieto Bonilla
article en
2 citations

Abstract

Recommendations advise factor IX desensitization before immune tolerance induction in severe hemophilia B, supported by immunosuppression. A child with inhibitor and anaphylaxis to factor IX showed successful immunosuppression-free immune tolerance induction using very low and slowly increasing doses of a factor IX extended-half-life product. Immune tolerance to factor IX based on this protocol merits further study.

Clinical Case ReportsVol. 12(8)
Hospital Regional Universitario de Málaga (ES)
Responsible consumption and production
Openalex Percentile: Top 24%
Hemophilia Treatment and Research
0.91
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.